sanofi glp-1 First Generic Injection OK'd for Weight Loss Lilly launches GLP-1 pill, kicking

The revealed capacity of DSIP to increase the efficiency of oxidative phosphorylation found in vitro experiments could contribute to understanding pronounced stress protective and antioxidant action of this peptide in vivo

GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists improve glycemic control not only by enhancing glucose-dependent insulin secretion but also by suppressing glucagon release, reducing hepatic glucose output, slowing gastric emptying, and promoting satiety

Understanding where IGF-1 LR3 fits helps set appropriate expectations

Neuro endocrinology letters, 23(4), 365368

I would highly suggest for anyone thats on the fence

Cons: Slow Results: Some users note that fat loss is gradual, and the results may not be as dramatic as they anticipated